AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Aqua Bio Technology Share Issue/Capital Change 2026

Feb 27, 2026

3535_dva_2026-02-27_2593fe29-b6be-48cd-8383-08288a664d4e.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

abt
AQUA BIO TECHNOLOGY ASA
Press Release
27 February 2026 12:55:00 CET

Aqua Bio Technology ASA: Registration of share consolidation

Reference is made to the resolution by the general meeting of Aqua Bio Technology ASA (the "Company") on 16 February 2026 regarding a share consolidation (reverse share split) in the ratio 50:1, and the key information notice regarding the share consolidation announced on 25 February 2026.

The share consolidation has today been registered with the Norwegian Register of Business Enterprises. Following such registration, the share capital of the Company is NOK 16,139,675 divided into 3,227,935 shares, each with a par value of NOK 5.00.

Contacts

Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA
Phone: +47 9509 2322
Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-02-27 12:55 CET.